FDA to Add New Warning on Johnson & Johnson Covid Vaccine Related to Autoimmune Nerve Syndrome

The FDA will add a new warning on the Johnson & Johnson Covid vaccines related to an autoimmune nerve disorder, according to the Washington Post.

According to WaPo, the Food and Drug Administration will say the J&J Covid jab has been linked to “serious but rare side effects called Guillain-Barré syndrome.”

Guillain-Barré is a disorder in which the immune system attacks the nerves.

Via WaPo:

The Food and Drug Administration is preparing to announce a new warning for the Johnson & Johnson coronavirus vaccine saying the shot has been linked to a serious but rare side effect called Guillain-Barré syndrome, in which the immune system attacks the nerves, according to four individuals familiar with the situation.

About 100 Preliminary reports of Guillain-Barré have been detected after the administration of 12.8 million doses of Johnson & Johnson vaccine in the United States, the Centers for Disease Control and Prevention said in a statement Monday. The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 or older.

The Guillain-Barré cases are expected to be discussed as part of an upcoming meeting of the CDC’s Advisory Committee on Immunization Practices, the CDC said.

Guillain-Barré syndrome usually occurs at a rate of about 60 to 120 cases each week, according to CDC data. While the cause of the syndrome is not fully understood, it often follows infection with a virus, including influenza, or bacteria. Each year in the United States, an estimated 3,000 to 6,000 people develop the illness.

Photo of author
Cristina began writing for The Gateway Pundit in 2016 and she is now the Associate Editor.

You can email Cristina Laila here, and read more of Cristina Laila's articles here.

 

Thanks for sharing!